Cardiovascular diseases in adults

Our goal is to translate our world-class research into real-world applications that will have a meaningful impact on the prevention, diagnosis, and treatment of cardiovascular diseases in adults, ultimately enhancing patient outcomes and quality of life.

By promoting collaboration between industry, researchers, patients, and clinical teams, we aim to streamline the translation of novel cardiovascular technologies from bench to bedside to boardroom, advancing patient care and driving innovation in cardiology and cardiovascular medicine.

Leads

Headshot of Professor Divaka Perera

Professor Divaka Perera

Theme Lead
Professor Divaka Perera is the Theme Lead of Cardiovascular Diseases in Adults. He is a Cardiologist at Guy’s and St Thomas’ Hospital and Professor of Interventional Cardiology in the School of Cardiovascular Medicine & Sciences at King’s College London. He runs a translational research programme into the mechanisms and consequences of reduced blood supply to the heart muscle in chronic coronary artery disease, acute myocardial infarction and valve disease.
Headshot of Professor Amedeo Chiribiri

Professor Amedeo Chiribiri

HRC Director and Co-Theme Lead
Professor Amedeo Chiribiri is the HRC Director and Co-Theme Lead of Cardiovascular Diseases in Adults. He is a Consultant Cardiologist at GSTFT and Professor of Cardiovascular Imaging at King’s. He was the Director for the NIHR Cardiovascular MedTech Co-operative (MIC) at GSTFT, and oversees a large portfolio of industry collaborations. Professor Chiribiri's research is in cardiovascular imaging and biomedical engineering.
Professor Chiribiri is the Clinical Lead for Cardiovascular MRI and Head of Department for Cardiovascular Imaging at the School of Biomedical Engineering & Imaging Sciences (BMEIS), King’s. In these roles he leads the delivery of imaging and biomedical engineering clinical services, research and teaching, working closely with clinicians across the organisation, as well as local GPs and hospitals for tertiary services. The overarching strategy of his clinical and research activities is to apply innovative technologies to help improve patient outcomes and increase efficiency of care delivery.

Professor Chiribiri initiated and is the current Chair of the Special Interest Group on Quantitative Perfusion Magnetic Resonance Imaging (MRI) within the Society for Cardiovascular Magnetic Resonance (SCMR) and actively participates in both national and international bodies in the field of cardiovascular imaging. He advises the UK Department of Health and Social Care (DHSC) and Public Health England in the field of myocarditis and pericarditis in relation to receiving Covid-19 vaccinations.

Key clinical areas

Cardiovascular medicine
Structural heart disease
Electrophysiology
Heart failure

Target outcomes

1
Develop a team of health and care professionals with expertise in innovation and technology transfer in cardiology and cardiovascular medicine, supporting the health technology assessment pipeline.
2
Leverage local expertise for the technology evaluation of novel digital health solutions in collaboration with GSTFT clinicians and the HRC Methodological Theme.
3
Promote the creation of well-curated clinical databases, to accelerate evaluation of novel technologies.
4
Reduce inequalities and involve the public, patients and carers ensuring our research has Clinical impact.
OUR RESEARCH

Discovering cutting-edge imaging techniques that provide detailed insights into pulmonary blood flow, transforming diagnosis and management of pulmonary hypertension.

Enhancing accuracy and reliability in perfusion imaging through advanced validation and metrology tools designed for impaired tissue perfusion analysis.

Exploring the benefits of low-field MRI, offering cost-effective and patient-friendly solutions without compromising diagnostic accuracy.